GTHX Stock Price is down 77%, can it go higher? URGENT REPORT

GTHX Stock Price

G1 Therapeutics GTHX stock price is down -15% in the last...

Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more


MDVL Stock Price is up 73%, can it go higher? URGENT...
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) is Attrac...
TCBP Stock: TC BioPharm (NASDAQ:TCBP) Stock On Radar...

G1 Therapeutics GTHX stock price is down -15% in the last 5 days & -77% in the last year & volume is up 83% lately?

There is an old adage, “two heads are better than one”, so let’s collaborate on ECTM and compare notes.

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns. I believe the stock market is not gambling, it is also not fool proof, but I have developed a dependable system. I have found some critical components to success for GTHX, tell me what you think.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for GTHX is, a 🔥1 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT Stock Reporting system for breakout stocks.

To find out more about my story, CLICK HERE

[thrive_leads id=’28419′]

G1 Therapeutics Company Information

Company Name: G1 Therapeutics

Ticker: GTHX

Exchange: NASDAQ


G1 Therapeutics Company Summary:

G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.

GTHX stock price is due to News?

May 4th

G1 Therapeutics (GTHX Quick QuoteGTHX – Free Report) came out with a quarterly loss of $1.15 per share versus the Zacks Consensus Estimate of a loss of $0.99. This compares to loss of $0.65 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -16.16%. A quarter ago, it was expected that this company would post a loss of $1.03 per share when it actually produced a loss of $0.94, delivering a surprise of 8.74%.

GTHX stock price

GTHX Stock Price HOT Stock Grade:

The official heat level for ECTM is, a 🔥1 out of 4 . Here are my takeaways on it and why it is just a 1 out of 4. Do you agree?

EGTHX Trading Volume

The volume, is trading at an increase of 80% over the average which indicates a higher demand in the stock but it is down so that indicates selling pressure hence the bearish chart and reduction in price.

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

GTHX Technicals

The technical analysis “chart reading”, it is bearish and has been that way since the early part of last year with a steady descending channel.

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

GTHX News Cycle

The news, there is no significant positive news.

GTHX Fundamentals

The fundamentals, there is NO exciting financial filings associated with this stock, “-30% growth”!

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

GTHX Awareness

Marketing efforts “Awareness Campaigns”, I have not found marketing efforts around the investor awareness of this company. Hence the 1 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇

[thrive_leads id=’28419′]

Stay in the lopp :

Here's Who Just Picked Up Photomedex Inc (NAS...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Photomedex Inc (NASDAQ:PHMD) reported that Pell Lewis C has picked
Evoke Pharma Inc (NASDAQ:EVOK) Hits New High ...
Alpine 4 Technologies (ALPP) Stock Rockets 90...

related post

Skip to content